StockData
FibroBiologics, Inc. logo

FibroBiologics, Inc. (FBLG) stock

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30
$0.90−0.00 (-0.32%)

Close on Nov 17, 2026Market cap $6.00MP/E –Yield –

FibroBiologics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

FibroBiologics's price to book ratio was 0.8× on Nov 11, 2026, against 83.6× a year earlier. Over the last 2 years it ranged from 0.5× to 294.3×, with a median of 13.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.8×−67.8
2025Dec 31, 202568.6×+45.7
2024Dec 31, 202422.9×–

More FibroBiologics figures

See a number that looks wrong?